Beam Therapeutics Inc. - Jun 16, 2021 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)

Role: 10%+ Owner
Signature: /s/ Christine Bellon, SVP and CLO
Stock symbol: VERV
Transactions as of: Jun 16, 2021
Transactions value $: $0
Form type: 3
Date filed: 6/16/2021, 09:11 PM
Next filing: Jun 23, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VERV	Common Stock						276K	Jun 16, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VERV	Series A Convertible Preferred Stock							Jun 16, 2021	Common Stock	271K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of the convertible preferred stock is convertible at any time, at the holder's election, into 0.108 shares of common stock, and will convert automatically upon the issuer's consummation of an initial public offering. The preferred stock has no expiration date.